Antares Pharma, Inc. (NASDAQ:ATRS):
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Antares Pharma, Inc. (ATRS) & Lead Plaintiff Deadline: December 22, 2017.
The company is so far trading down since yesterday’s close of 2.21.
Antares Pharma, Inc. (Antares), launched on April 29, 2005, is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops, manufactures and commercializes therapeutic products using its drug delivery systems. Its subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injector system suitable for branded and generic injectable drugs in unit dose containers, reusable needle-free spring-action injector devices, and disposable multi-use pen injectors for use with cartridges. The Company makes a reusable, needle-free spring action injection device, ZOMA-Jet or Twin-Jector, which is marketed through its partners for use with human growth hormone (hGH). The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies..
The stock is trading at $2.13 significantly lower than the 50 day moving average which is $3.04 and much lower than the 200 day moving average of $2.97. The 50 day moving average was down $-0.91 or -30.03% and the 200 day average was down $-0.84.
In the last earnings report the EPS was $-0.12 and is expected to be $-0.11 for the current year with 156,407,000 shares now outstanding. Next quarter’s EPS is estimated at $-0.04 with next year’s EPS anticipated to be $0.01.
Short traders are feeling a little more bullish on Antares Pharma, Inc. of late as inferred by the fall in short interest. The firm recorded a fall in short interest from September 15, 2017 to September 29, 2017 of -5.61%. Short shares fell from 6,183,269 to 5,836,408 over that timeframe. Days to cover decreased from 5.0 to 4.0 and the short interest percentage is 0.04% as of September 29.